The procedure was performed alongside staff at Memorial Ambulatory Surgery Center in Houston, according to a Sept. 9 LinkedIn post from Greg Hundemer, a Medtronic sales representative.
The FDA approved Vanta in June. The device has a battery life of up to 11 years, offering almost twice the device life of competitive primary cell devices.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.